TMPRSS2 and prostate carcinoma: Gene fusions involving the androgen-regulated gene TMPRSS2 and ERG, a member of the ETS family of transcription factors, occur in about 50% of prostate cancers, especially in young patients, and result in strong ERG protein overexpression [53-55].